Veralto Co. (NYSE:VLTO) Shares Sold by Arthur M. Cohen & Associates LLC

Arthur M. Cohen & Associates LLC decreased its holdings in shares of Veralto Co. (NYSE:VLTO) by 2.6% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 49,243 shares of the company’s stock after selling 1,299 shares during the quarter. Veralto comprises 0.9% of Arthur M. Cohen & Associates LLC’s holdings, making the stock its 21st largest holding. Arthur M. Cohen & Associates LLC’s holdings in Veralto were worth $4,799,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the business. Savant Capital LLC grew its stake in shares of Veralto by 0.5% in the fourth quarter. Savant Capital LLC now owns 20,177 shares of the company’s stock valued at $2,055,000 after buying an additional 98 shares in the last quarter. Allworth Financial LP grew its stake in shares of Veralto by 19.4% in the fourth quarter. Allworth Financial LP now owns 622 shares of the company’s stock valued at $64,000 after buying an additional 101 shares in the last quarter. Quent Capital LLC grew its stake in shares of Veralto by 17.3% in the fourth quarter. Quent Capital LLC now owns 699 shares of the company’s stock valued at $71,000 after buying an additional 103 shares in the last quarter. Coldstream Capital Management Inc. grew its stake in shares of Veralto by 1.7% in the fourth quarter. Coldstream Capital Management Inc. now owns 6,405 shares of the company’s stock valued at $652,000 after buying an additional 110 shares in the last quarter. Finally, Connor Clark & Lunn Investment Management Ltd. grew its stake in shares of Veralto by 4.1% in the fourth quarter. Connor Clark & Lunn Investment Management Ltd. now owns 2,967 shares of the company’s stock valued at $302,000 after buying an additional 117 shares in the last quarter. Institutional investors and hedge funds own 91.28% of the company’s stock.

Veralto Trading Down 1.4%

NYSE:VLTO opened at $99.00 on Thursday. The firm has a market cap of $24.54 billion, a PE ratio of 29.64, a price-to-earnings-growth ratio of 4.24 and a beta of 0.99. The company has a current ratio of 1.92, a quick ratio of 1.69 and a debt-to-equity ratio of 1.27. The stock has a fifty day moving average price of $95.23 and a 200 day moving average price of $99.45. Veralto Co. has a 12-month low of $83.87 and a 12-month high of $115.00.

Veralto (NYSE:VLTO) last announced its quarterly earnings results on Tuesday, April 29th. The company reported $0.95 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.87 by $0.08. The company had revenue of $1.33 billion during the quarter, compared to the consensus estimate of $1.28 billion. Veralto had a return on equity of 49.29% and a net margin of 16.04%. Veralto’s revenue for the quarter was up 6.9% on a year-over-year basis. During the same period in the previous year, the business earned $0.84 EPS. Sell-side analysts anticipate that Veralto Co. will post 3.66 earnings per share for the current fiscal year.

Veralto Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Thursday, July 31st. Shareholders of record on Monday, June 30th will be issued a dividend of $0.11 per share. This represents a $0.44 dividend on an annualized basis and a yield of 0.44%. The ex-dividend date of this dividend is Monday, June 30th. Veralto’s dividend payout ratio (DPR) is 12.57%.

Insiders Place Their Bets

In other news, SVP Surekha Trivedi sold 848 shares of Veralto stock in a transaction dated Monday, June 2nd. The stock was sold at an average price of $100.55, for a total transaction of $85,266.40. Following the sale, the senior vice president now owns 8,433 shares in the company, valued at approximately $847,938.15. The trade was a 9.14% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CEO Jennifer Honeycutt sold 10,414 shares of Veralto stock in a transaction dated Monday, March 24th. The stock was sold at an average price of $98.56, for a total value of $1,026,403.84. Following the sale, the chief executive officer now owns 116,637 shares in the company, valued at $11,495,742.72. This trade represents a 8.20% decrease in their position. The disclosure for this sale can be found here. Insiders sold 56,917 shares of company stock valued at $5,423,033 in the last ninety days. Insiders own 0.36% of the company’s stock.

Wall Street Analysts Forecast Growth

VLTO has been the subject of a number of research reports. Northcoast Research initiated coverage on Veralto in a research note on Tuesday, May 6th. They issued a “buy” rating and a $110.00 price objective for the company. Robert W. Baird lifted their price objective on Veralto from $105.00 to $106.00 and gave the company a “neutral” rating in a research note on Thursday, May 1st. Citigroup decreased their target price on Veralto from $116.00 to $100.00 and set a “neutral” rating for the company in a report on Monday, April 14th. Stifel Nicolaus lifted their target price on Veralto from $102.00 to $104.00 and gave the company a “buy” rating in a report on Thursday, May 1st. Finally, Royal Bank of Canada lifted their target price on Veralto from $103.00 to $104.00 and gave the company a “sector perform” rating in a report on Thursday, May 1st. Six analysts have rated the stock with a hold rating and five have issued a buy rating to the company’s stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Hold” and an average target price of $110.09.

About Veralto

Veralto Corporation provides water analytics, water treatment, marking and coding, and packaging and color services worldwide. It operates through two segments, Water Quality (WQ) and Product Quality & Innovation (PQI). The WQ segment offers precision instrumentation and water treatment technologies to measure, analyze, and treat water in residential, commercial, municipal, industrial, research, and natural resource applications through the Hach, Trojan Technologies, and ChemTreat brands.